Regulation of protein-DNA interactions at the interferon-γ gene promoter by corticosteroids. Implications for inflammatory bowel diseases

Annals of the New York Academy of Sciences

Volumn 859, Issue , 1998, Pages 194-197

  Barbulescu, Karina ^a   Becker, Christoph ^a   Büschenfelde, Karl hermann Meyer Zum ^a   Neurath, Markus F ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CD45 ANTIGEN; CORTICOSTEROID; CYTOKINE; GAMMA INTERFERON; IMMUNOSUPPRESSIVE AGENT; PLEIOTROPHIN;

CONFERENCE PAPER; CONTROLLED STUDY; ENTERITIS; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; IMMUNOMODULATION; INFLAMMATION; LEUKEMIA CELL LINE; MEMORY CELL; NATURAL KILLER CELL; PROMOTER REGION; PROTEIN DNA INTERACTION; T LYMPHOCYTE;

EID: 0032406169     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1998.tb11126.x     Document Type: Conference Paper

References (6)

1. + lamina propria (LP) lymphokine secretion profiles in inflammatory bowel disease. J. Immunol. 157: 1261.
2. 2. TRINCHIERI, G. & B. PERUSSIA. 1985. Immune interferon: A pleiotropic lymphokine with multiple effects. Immunol. Today 6: 131.
3. + lymphocytes. Eur. J. Immunol. 25: 644.
4. 4. BARBULESCU, K. et al. 1997. Protein/DNA interactions in vivo of the interferon-γ promoter in in vivo CD45RA and CD45RO T helper subsets. Eur. J. Immunol. 27:1098.
5. 5. AUSUBEL, F. M. et al. 1995. Transfection using DEAE-Dextran. Curr. Proto. Mol. Biol. Vol. 1: unit 9.2.
6. 6. BREESE, E. J. et al. 1995. The effect of treatment on lymphokine secreting cells in the intestinal mucosa of children with Crohn's disease. Aliment. Pharmacol. Ther. 9: 547.